X-16609606-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_175859.3(CTPS2):āc.1626G>Cā(p.Gly542Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000304 in 1,209,204 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 101 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0015 ( 0 hom., 47 hem., cov: 23)
Exomes š: 0.00018 ( 0 hom. 54 hem. )
Consequence
CTPS2
NM_175859.3 synonymous
NM_175859.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.64
Genes affected
CTPS2 (HGNC:2520): (CTP synthase 2) The protein encoded by this gene catalyzes the formation of CTP from UTP with the concomitant deamination of glutamine to glutamate. This protein is the rate-limiting enzyme in the synthesis of cytosine nucleotides, which play an important role in various metabolic processes and provide the precursors necessary for the synthesis of RNA and DNA. Cancer cells that exhibit increased cell proliferation also exhibit an increased activity of this encoded protein. Thus, this protein is an attractive target for selective chemotherapy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant X-16609606-C-G is Benign according to our data. Variant chrX-16609606-C-G is described in ClinVar as [Benign]. Clinvar id is 721651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.64 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 47 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTPS2 | NM_175859.3 | c.1626G>C | p.Gly542Gly | synonymous_variant | 17/19 | ENST00000359276.9 | NP_787055.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTPS2 | ENST00000359276.9 | c.1626G>C | p.Gly542Gly | synonymous_variant | 17/19 | 1 | NM_175859.3 | ENSP00000352222.4 | ||
CTPS2 | ENST00000380241.7 | c.1626G>C | p.Gly542Gly | synonymous_variant | 17/19 | 1 | ENSP00000369590.3 | |||
CTPS2 | ENST00000443824.5 | c.1626G>C | p.Gly542Gly | synonymous_variant | 17/19 | 2 | ENSP00000401264.1 |
Frequencies
GnomAD3 genomes AF: 0.00147 AC: 164AN: 111550Hom.: 0 Cov.: 23 AF XY: 0.00139 AC XY: 47AN XY: 33740
GnomAD3 genomes
AF:
AC:
164
AN:
111550
Hom.:
Cov.:
23
AF XY:
AC XY:
47
AN XY:
33740
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000409 AC: 75AN: 183356Hom.: 0 AF XY: 0.000265 AC XY: 18AN XY: 67800
GnomAD3 exomes
AF:
AC:
75
AN:
183356
Hom.:
AF XY:
AC XY:
18
AN XY:
67800
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000185 AC: 203AN: 1097602Hom.: 0 Cov.: 29 AF XY: 0.000149 AC XY: 54AN XY: 362964
GnomAD4 exome
AF:
AC:
203
AN:
1097602
Hom.:
Cov.:
29
AF XY:
AC XY:
54
AN XY:
362964
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00147 AC: 164AN: 111602Hom.: 0 Cov.: 23 AF XY: 0.00139 AC XY: 47AN XY: 33802
GnomAD4 genome
AF:
AC:
164
AN:
111602
Hom.:
Cov.:
23
AF XY:
AC XY:
47
AN XY:
33802
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 05, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at